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Abstract 
 
This study evaluated the effects of ingesting sodium bicarbonate (NaHCO3) or caffeine 
individually, or in combination, on high-intensity cycling capacity. In a 
counterbalanced, crossover design, thirteen healthy non-cycling trained males (age: 
21±3 years, height: 178±6 cm, body mass: 76±12 kg, WPEAK: 230±34 W, V̇O2PEAK: 
46±8 ml.kg-1.min-1) performed a graded incremental exercise test, two familiarisation 
trials and four experimental trials. Trials consisted of cycling to volitional exhaustion at 
100% WPEAK (TLIM) 60 min after ingesting a solution containing either: (1) 0.3 g.kg-1 
body mass sodium bicarbonate (BIC), (2) 5 mg.kg-1 body mass caffeine plus 0.1 g.kg-
1 body mass sodium chloride (CAF), (3) 0.3 g.kg-1 body mass sodium bicarbonate plus 
5 mg.kg-1 body mass caffeine (BIC-CAF) or (4) 0.1 g.kg-1 body mass sodium chloride 
(PLA). Experimental solutions were administered double-blind. Pre-exercise, at the 
end of exercise and 5 min post-exercise blood pH, base excess [BE] and bicarbonate 
ion concentration [HCO3-] were significantly elevated for BIC and BIC-CAF compared 
with CAF and PLA. TLIM (median; interquartile range (IQR)) was significantly greater 
for CAF (399; 350-415 s; P=0.039; r=0.6) and BIC-CAF (367; 333-402 s; P=0.028; 
r=0.6) compared to BIC (313: 284-448 s) although not compared to PLA (358; 290-
433 s; P=0.249, r=0.3 and P=0.099 and r=0.5, respectively). There were no 
differences between PLA and BIC (P=0.196; r=0.4) or between CAF and BIC-CAF 
(P=0.753; r=0.1). Relatively large inter and intra individual variation was observed 
when comparing treatments and therefore an individual approach to supplementation 
appears warranted. 
 
Key words: Caffeine, Sodium bicarbonate, Alkalosis, Metabolic buffers, Cycling  
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Introduction 
 
The individual ergogenicity of both caffeine and sodium bicarbonate (NaHCO3) has 
been extensively evaluated in vivo (Higgins et al. 2013a; Meyers and Cafarelli 2005; 
Simmonds et al. 2010) and in vitro (Higgins et al. 2013b; Tallis et al. 2012; Tallis et al. 
2013). Although not uniformly equivocal, recent evidence suggests that individually 
both caffeine (Simmonds et al. 2010) and NaHCO3 (Higgins et al. 2013a) can exert 
ergogenic benefits on high-intensity exercise capacity (+15% at 120% V̇O2PEAK and 
+17% at 100% peak power output (WPEAK), respectively). With caffeine and NaHCO3 
eliciting performance enhancing effects by different mechanisms, a synergistic effect 
may occur resulting in substantial performance gains. However, to the best of our 
knowledge only four studies have evaluated the effects of combining caffeine and 
NaHCO3 on exercise performance in vivo (Carr et al. 2011; Christensen et al. 2014; 
Kilding et al. 2012; Pruscino et al. 2008). 
 
Carr et al. (2011) reported that compared with placebo (PLA) 6 mg.kg-1 body mass 
caffeine improved power output in elite males during 2000-m rowing by 2.3%. This 
increase in PO contributed to a 3 seconds quicker completion time and in the context 
of the magnitude based inference statistical approach adopted by the authors was 
reported as very close to a substantial difference. In contrast, Carr et al. (2011) 
reported that the differences in PO and completion time between NaHCO3 and PLA 
(0.6%, 0.6 s) and combined NaHCO3 and caffeine and PLA (1.7%, -1.2 s) were 
unclear.  More simply, ingestion of NaHCO3 did not appear to augment 2000 m rowing 
performance compared to PLA. Interestingly the ingestion of caffeine with NaHCO3 
resulted in a greater PO (1.1%) and faster completion time (-1.8 s) compared with 
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NaHCO3 alone suggesting that caffeine ingestion somewhat ameliorated the 
performance decrement reported after isolated NaHCO3 ingestion, compared to PLA. 
However, it should be pointed out that all participants reported gastrointestinal (GI) 
issues including nausea, vomiting and stomach pain after NaHCO3 ingestion, 
regardless if coingested with caffeine. When considering the between treatment 
coefficient of variation for mean performance time was 0.4%, it is plausible that these 
GI issues might have modulated the potential ergogenicity of NaHCO3. 
 
Pruscino et al. (2008) reported that caffeine alone negatively impacted repeated 200 
m freestyle swimming performance compared with all treatments (range: -1.5 to -
0.9%). Performance was significantly slower with caffeine compared to NaHCO3 (-
1.5±0.7%) and NaHCO3 and caffeine combined (-1.2±1.0%). In contrast, performance 
with NaHCO3 was quicker compared to all treatments (range: 0.3 to 0.7%) regardless 
whether ingested in isolation or with caffeine. Indeed, the largest reported performance 
improvement, albeit small, was for NaHCO3 alone versus placebo (0.7±0.7% faster). 
However, it should be pointed out that the sample size for this study was relatively 
small (n=6) so results should be interpreted with caution. More recently Kilding et al. 
(2012) reported that in comparison to placebo both caffeine and NaHCO3 significantly 
enhanced mean power output during 3-km time-trial performance in trained male 
cyclists (2.1% and 2.7%, respectively) although the ergogenic effects were not additive 
(2.4%). Based on the evidence to date the combinatorial effects of NaHCO3 and 
caffeine on physical performance are therefore equivocal.  
In addition to the aforementioned GI distress it seems plausible that differences in 
experimental approach between studies might have contributed to the differences in 
results previously reported. For example, although each study adopted a dosage of 
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0.3 g.kg-1 NaHCO3, the dosage of caffeine varied between studies with Pruscino et al. 
(2008) and Carr et al. (2011) adopting ~6 mg.kg-1 whereas Kilding et al. (2012) and 
Christensen et al. (2014) adopted 3 mg.kg-1. Additionally there were differences in 
approaches to abstinence of caffeine intake prior to exercise, an area recognised to 
limit the ability to compare studies evaluating the ergogenic effects of caffeine (Tallis 
et al. 2015). For example, participants in Carr et al. (2011) and Pruscino et al. (2008) 
abstained for 48 hours prior to exercise whereas participants in Kilding et al. (2012) 
abstained for the duration of the study. Participants in Christensen et al. (2014) were 
asked to avoid caffeine drinks 36 hours prior to testing. Furthermore, differences in 
exercise modality and protocol (e.g. repeated 200 m freestyle swimming (Pruscino et 
al. 2008), 2000 m rowing (Carr et al. 2011), 3 km time trial cycling (Kilding et al. 2012) 
and 6 min maximal rowing (Christensen et al. 2014)) might have contributed to 
differences between studies. 
 
Each of the previous studies that have examined combined caffeine and NaHCO3 
ingestion on exercise performance evaluated well trained participants which might also 
have contributed to why no clear synergistic ergogenic benefit has been observed. 
Indeed it is now well established that individuals who undertake high-intensity training 
have elevated levels of muscle carnosine compared with endurance trained and 
untrained individuals (Parkhouse and McKenzie 1984; Parkhouse et al. 1985). 
Carnosine, an intracellular buffer, is thought to play an important role in the 
homeostasis of muscle cells during high-intensity exercise (Derave et al. 2010) and 
thus might ‘offset’ any potential ergogenic contribution from NaHCO3 (Aschenbach et 
al. 2000; Derave et al. 2010). A recent meta-analysis demonstrated that the overall 
mean effect of NaHCO3 on exercise performance was more than 225% greater in 
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untrained (effect size; 95%CI: 0.59; 0.36-0.95) compared to trained (0.18; 0.13-0.33) 
individuals (Peart et al. 2012). The difference between untrained (0.69; -0.07-1.63) 
and trained (0.19; -0.58-1.07) individuals was particularly large (263%) for research 
using a time to volitional fatigue (TLIM) protocol (i.e. exercise capacity). This is 
supported by Matson and Tran (1993) who suggest that using TLIM is most likely to 
demonstrate ergogenic benefit for NaHCO3 supplementation. Indeed, recent research 
has demonstrated that ergogenic benefit with NaHCO3 ingestion is most likely 
observed for TLIM at 100% WPEAK (Higgins et al. 2013a). Similarly, Simmonds et al. 
(2010) demonstrated that 5 mg.kg-1 caffeine increased TLIM at 120% V̇O2PEAK by ~15% 
although the ergogenic effects of caffeine are generally more pronounced in trained 
compared to non-trained individuals (Simmonds et al. 2010; Tallis et al. 2015).  
 
Due to the small number of studies and myriad of differences between experimental 
approaches the potential synergistic benefit of NaHCO3 and caffeine outside the 
trained population is not currently known. This is important as there is evidence that 
increasing numbers of recreational athletes, the vast majority males, are both using 
and/or want to understand the safety and presumably efficacy of performance 
enhancing substances (Bojsen-Møller and Christiansen 2010). Moreover, both 
NaHCO3 and caffeine are now widely available and marketed to recreational athletes1. 
The present study therefore sought to address this gap in the literature by examining 
the effects of NaHCO3 and caffeine, ingested individually and simultaneously, on TLIM 
in healthy but not specifically cycling trained males. We hypothesised that ingesting 
NaHCO3 and caffeine individually would enhance TLIM versus placebo. Additionally, 
                                                          
1 See http://gonutrition.com/sodium-bicarbonate and http://gonutrition.com/caffeine-200. Accessed 29th 
September 2015. 
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we hypothesised that ingesting NaHCO3 and caffeine simultaneously would enhance 
TLIM versus all experimental conditions. 
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Materials and methods 
 
Participants 
 
Thirteen healthy, non-cycling trained males (age 21 ± 3 years, height 178 ± 6 cm, body 
mass 76 ± 12 kg, WPEAK 230 ± 34 W, V̇O2PEAK 46 ± 8ml.kg-1.min-1) volunteered for this 
study which had received University Ethics Committee approval. All participants were 
recreationally active (engaging in physical activity at least twice weekly and were 
primarily team sport athletes or middle distance runners; International Physical Activity 
Questionnaire (IPAQ) score: 5679 +/- 6688 MET-min/week) although not specifically 
cycling trained. Participants that completed the study habitually consumed caffeine, 
but were not heavy caffeine users (125 ± 95 mg/day). Caffeine intake was measured 
using a 24 hour recall questionnaire (Maughan 1999). 
 
Pre-experimental procedures 
 
Participants were screened to ensure that they were not currently undertaking or had 
undertaken a nutritional regime involving any alkalotic buffers such as NaHCO3, 
sodium citrate or β-alanine within the previous 3–6 months. Due to the high-intensity 
nature of the exercise trials participants were reminded to consume a balanced body 
mass maintaining diet (~50% carbohydrate, ~30% protein and ~20% fat) throughout 
the study. All of this nutritional information was included in the participant information 
sheet provided and confirmed verbally before participants gave written informed 
consent. Each participant also completed a general health screening questionnaire 
before each trial. Participants visited the laboratory on seven occasions and reported 
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for each trial two to three hours postprandial. Trials were conducted at the same time 
of day to avoid possible circadian rhythmic effects on exercise performance (Cappaert 
1999).  
 
Study design 
 
On the first visit participants completed a graded incremental exercise test to 
determine V̇O2PEAK and WPEAK. After at least 48 hours rest participants undertook the 
first of their two familiarisation trials at a constant load equivalent to 100% WPEAK (TLIM; 
Higgins et al. 2014). On the subsequent four visits, each separated by at least 48 
hours, participants completed TLIM at 100% WPEAK 60 mins after consuming solutions 
containing either: (1) 0.3 g.kg-1 body mass sodium bicarbonate (BIC), (2) 5 mg.kg-1 
body mass caffeine plus 0.1 g.kg-1 body mass sodium chloride (CAF), (3) 0.3 g.kg-1 
body mass sodium bicarbonate plus 5 mg.kg-1 body mass caffeine (BIC-CAF) or (4) 
0.1 g.kg-1 body mass sodium chloride (PLA). Both 0.3 g.kg-1 NaHCO3 (Higgins et al. 
2013a) and 5 mg.kg-1 caffeine (Simmonds et al. 2010) have been demonstrated to 
augment high-intensity cycling capacity. Experimental solutions were administered 
double-blind. In addition to the relevant solute, each solution consisted of 4 ml.kg-1 tap 
water and 1 ml.kg-1 of double strength no added sugar orange squash (Sainsbury’s, 
London, UK). A dosage of 0.1 g.kg-1 body mass of sodium chloride (NaCl) was added 
to CAF and PLA drinks to taste match the NaHCO3 containing solutions as closely as 
possible. All solutions were refrigerated overnight before consumption to enhance 
palatability (Higgins et al. 2013a). 
 
Graded incremental exercise test  
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Before commencing the graded incremental exercise test, participants selected the 
seat and pedal strap positions that felt most comfortable ensuring that the leg was 
slightly flexed when the foot reached the bottom of each duty cycle. These settings 
were adopted for all subsequent trials. Participants were then seated and linked to a 
gas analysis system and rested quietly for five minutes. Expired gas was analysed 
using an online breath-by-breath system (Metamax 3B, Cortex Biophysik, Leipzig, 
Germany). Before each test the system was calibrated for gas concentration (5% CO2 
and 15% O2, British Oxygen Company, Surrey, UK) using a 6 litre antistatic 
rebreathable bag (Harvard Apparatus Ltd, Kent, UK), volume measured using a 3 litre 
calibration syringe (Hans Rudolf Inc, Kansas, USA) and atmospheric pressure 
measured from a wall mounted mercury barometer (F. Dalton & Co Ltd, Watford, UK). 
Baseline data was averaged over the last sixty seconds of the rest period and for the 
last ten seconds of exercise. Expired gas was continually monitored and values for V̇E, 
V̇O2 and RER, subsequently calculated. Heart rate (HR) was measured using a 
telemetric HR monitor (Polar FS1, Kempele, Finland). Participants were blinded to the 
clock during rest to minimise any anticipatory changes in baseline physiology.  Prior 
to commencing exercise resting blood lactate concentration ([BLa]) was obtained by 
means of a fingerprick capillary sample. The finger was wiped with an isopropyl alcohol 
swab (Medlock Medical, Oldham, UK), punctured using a 1.8 mm lancing device 
(Safety Lancet, Sarstedt, Germany) and the initial blood wiped away with a tissue. A 
20 μl sample was collected in a sodium heparinised capillary tube (EKF Diagnostic, 
Magdeburg, Germany) and then added to a 2 ml Eppendorf tube which was pre-filled 
with 1ml of haemolysing solution (EKF Diagnostic, Magdeburg, Germany) and mixed 
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well. Samples were then analysed for [BLa] (Biosen C_line, EKF Diagnostic, 
Magdeburg, Germany).  
 
Cycling commenced on the ergometer (Monark 824E Ergomedic, Monark, Varberg, 
Sweden) at a cadence of 70 rev.min-1 with an unloaded cradle (70 W) increasing by 
35 W every three minutes until volitional exhaustion. Researchers provided verbal 
feedback for maintenance of the specified cadence and to complete a maximal effort.  
During the last five seconds of each stage HR and ratings of perceived exertion (RPE; 
6-20 scale) (Borg 1982) were recorded. Heart rate and RPE were recorded at volitional 
exhaustion and further [BLa] samples were taken upon completion of exercise and five 
minutes post-exercise. WPEAK was calculated as the mean power achieved during the 
final minute of the test (Lamberts et al. 2012). If exhaustion occurred less than one 
minute into a stage the appropriate duration undertaken at each power output was 
used to calculate a pro-rata WPEAK (Higgins et al. 2013a).  
 
Experimental Trials 
 
After five minutes seated rest HR, perceived readiness to exercise (PRE), abdominal 
discomfort (AD) and gut fullness (GF; Higgins et al. 2013a) were recorded. A 
fingerprick capillary blood sample was collected and analysed for [BLa] as previously 
described. A second capillary blood sample was then collected in a 100 μl clinitube 
(Radiometer Medical ApS, Copenhagen, Denmark), capped at both ends and mixed 
well. Samples were then analysed for pH, base excess ([BE]) and bicarbonate ion 
concentration ([HCO3-]) using a blood gas analyser (ABL5 radiometer, Radiometer 
Medical ApS, Copenhagen, Denmark). 
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After baseline measurements were completed the participant consumed the 
experimental solution within the first 5 mins of the 60 mins pre-exercise period. 
Participants remained seated throughout and were allowed to consume water ad 
libitum to minimise gastrointestinal (GI) discomfort. The mean volume of water 
consumed was monitored and was similar between treatments: CAF (n=11): 251 ± 
205 ml, BIC (n=12): 268 ± 157 ml, BIC-CAF (n=11): 381 ± 220 ml, and PLA (n=10): 
236 ± 158 ml (n = number of measurements analysed per treatment). Perceived 
readiness to exercise, AD and GF were recorded at 30 mins and 60 mins following 
ingestion. Approximately 45 min following treatment ingestion participants were linked 
to the gas analysis system and expired gas was continually monitored and values for 
V̇E, V̇O2 and RER, subsequently calculated. Baseline data was averaged over the last 
sixty seconds of the rest period and for the last ten seconds of exercise. At 60 min 
following treatment ingestion HR was recorded and further blood samples taken for 
[BLa], pH, [BE] and [HCO3-]. Subsequently each participant completed the TLIM test at 
100% WPEAK.  The TLIM test commenced with a warm up consisting of cycling at 70 
rev.min-1 for 4 min at 50% WPEAK, 1 min at 75% WPEAK and then 2 min at 70 W 
(unloaded ergometer). After a verbal countdown the test commenced with participants 
blinded to the clock throughout. The cadence of 70 rev.min-1 was chosen as research 
examining a range of power outputs (100 – 300 W) and cycling cadences (30 – 120 
rev.min-1) during constant load cycling found 70 rev.min-1 to be optimal from both 
metabolic and respiratory perspectives (Ansley and Cangley 2009). A stationary start 
was employed which has previously been used in evaluating high-intensity cycling in 
a laboratory setting with active but not specifically cycling trained males, similar to the 
present study (Wittekind et al. 2011). Ratings of perceived exertion for localised RPE 
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(RPEL), representing the exercising muscles, and overall RPE (RPEO), reflective of 
cardiovascular strain were recorded after 1, 2 and 3 min of exercise. Abdominal 
discomfort, GF and HR were recorded and blood samples taken for [BLa], pH, [BE] 
and [HCO3-] immediately post-exercise with final blood samples taken 5 minutes post-
exercise. The test was ceased the second time the cadence dropped below 70 
rev.min-1 for more than 3 or 4 seconds or if the participant was unable to re-establish 
the required cadence within 3 to 4 seconds (Higgins et al. 2013a). Upon completion of 
the test, the participant was encouraged to warm down for 5 minutes by cycling at 70 
W. Familiarisation trials were similar to experimental trials but excluded the treatment 
and subsequent 60 min ingestion period. 
 
Statistical analysis 
 
Statistical analysis was completed using SPSS (IBM v21, Chicago, USA). For all data 
normality (Shapiro-Wilk) and homogeneity of variance/sphericity (Mauchly) were 
checked prior to choosing the appropriate parametric or non-parametric statistical 
tests. In limited instances a parametric test was chosen despite the majority of data 
not being normally distributed (i.e. RPEL, RPEO and AD). This was decided so as to 
minimise the potential for type I error due to multiple individual (non-parametric) 
comparisons and/or to ensure consistency and comparable analysis to other similar 
variables. 
 
Where data was normally distributed this is presented as the mean ± SD. Where data 
is not normally distributed, this is presented as the median and interquartile range 
(IQR). The IQR range highlights where the middle 50% of the data lies and is the range 
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between the bottom and top quartiles. Similar to the median, the IQR is appropriate 
when data are not symmetrically distributed (Whitley and Ball 2002).  For any 
violations of sphericity, degrees of freedom were corrected using Huynh-Feldt (ε 
>0.75) or Greenhouse-Geisser (ε < 0.75) values for ε, where applicable (Field 2005). 
For 2-way repeated measures ANOVAs Bonferroni corrections for multiple 
comparisons were applied. Tukeys’ HSD post hoc analysis was undertaken for 
interactions by calculating the difference required between means for significance at 
the minimum level of P=0.05 (Vincent and Weir 2012). The time points considered for 
HR and blood variables were pre-ingestion (-60 min), pre-exercise (0 min), at the end 
of exercise and five minutes post-exercise. Respiratory data (V̇O2, V̇E and RER) was 
considered at rest and during the final 10 seconds of exercise. Values for RPEL and 
RPEO were analysed at 1 min, 2 min, and 3 min during exercise and at volitional 
exhaustion. Abdominal discomfort and GF were analysed pre-ingestion, 30 min post-
ingestion, pre-exercise (60 min post-ingestion) and at the end of exercise. Finally, PRE 
was analysed pre-ingestion, 30 min post-ingestion and pre-exercise (60 min post-
ingestion).   
 
Data were analysed and quantified using a mixture of effect sizes (ES), P values 
(minimum requirement of P≤0.05) and, where appropriate, 95% confidence intervals. 
For ANOVA main effects and interactions the ES is reported as the partial η2 value. 
Otherwise, for normally distributed data the ES (d) was calculated using the difference 
in means divided by the pooled SD of the compared trials (Nakagawa and Cuthill 
2007). For non-normally distributed data the ES (r) was calculated as Z / √ n (Ivarsson 
et al. 2013). For non-normally distributed data confidence intervals were calculated as 
described by Conover (1980).  
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Results 
 
Preliminary tests 
 
V̇O2, V̇E, HR, [BLa] and RPE at the end of the graded incremental exercise test were 
3.42±0.35 l.min-1 (46±8 ml.kg-1.min-1), 129.9±14.3 l.min-1, 184±10 bpm-1, 12.5±3.0 
mmol.l-1 and 19±1, respectively (NB: V̇O2 and V̇E data are n=12 due to equipment 
failure during data collection). This data supports the criteria for achievement of valid 
peak oxygen uptake tests (Bird and Davison 1997). Mean minute peak power output 
(WPEAK) was 230±34 W.  
 
Exercise Capacity 
 
Figure 1 highlights TLIM data (median; IQR) for the experimental treatments (CAF: 399 
s (350-415 s), BIC: 313 s (284-448 s), BIC-CAF: 367 s (333-402 s) and PLA: 358 s 
(290-433 s)). With the exception of CAF vs. BIC (P=0.039, r=0.6) and BIC-CAF vs. 
BIC (P=0.028; r=0.6) there were no differences between treatments at the group level. 
However, there was relatively large inter and intra individual variation (Table 1). 
 
*** Figure 1 and Table 1 near here *** 
 
Cardio-respiratory variables 
 
A treatment * time interaction (P<0.001; η2=0.3) was observed for HR.  At the end of 
exercise HR for both BIC-CAF (183±11 bpm-1; P=0.01; d=0.7) and CAF (182±11 bpm-
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1, P<0.05; d=0.6) were greater than PLA (175±11 bpm-1), respectively. Five minutes 
post-exercise BIC-CAF (123±10 bpm-1) was greater than PLA (111±9 bpm-1; P<0.01; 
d=1.3), BIC (113±9 bpm-1; P<0.01; d=1.0) and CAF (115±10 bpm-1; P<0.01; d=0.8). 
Main effects for time (P<0.001; η2=1.0) were observed for V̇O2, V̇E and RER with mean 
values at the end of exercise of 3.59±0.70 l.min-1, 134.2±26.8 l.min-1 and 1.11±0.10, 
respectively. 
 
Blood variables 
 
A treatment * time interaction (P<0.001; η2=0.4) was observed for [BLa]. Post-hoc 
analysis revealed that at the end of exercise [BLa] for BIC-CAF (15.8±3.5 mmol.l-1) 
was greater than PLA (12.6±3.3 mmol.l-1, P<0.01; d=0.9) and CAF (13.5±3.4 mmol.l-
1, P<0.01; d=0.7). In addition [BLa] for BIC (14.7±3.3 mmol.l-1) was greater than PLA 
(P<0.01; d=0.6). Five minutes post-exercise [BLa] for BIC-CAF (15.2±3.7 mmol.l-1) 
was greater than CAF (12.8±3.2 mmol.l-1, P<0.01; d=0.7) and PLA (11.4±3.4 mmol.l-
1, P<0.01; d=1.1). Finally, BIC (13.7±3.3 mmol.l-1) was greater than PLA (P<0.01; 
d=0.7). Treatment * time interactions were observed for [HCO3-] (P<0.001; η2=0.6), 
[BE] (P<0.001; η2=0.5) and pH (P<0.001; η2=0.6). Compared to CAF and PLA, acid-
base balance significantly increased pre-exercise (60 min post-ingestion) for BIC and 
BIC-CAF and remained elevated at the end of exercise and 5 min post-exercise (Table 
2, Figure 2). Interestingly, pH 5 min post-exercise was greater for BIC compared to 
CAF (P<0.01, d=2.0), BIC-CAF (P=0.01, d=0.7) and PLA (P<0.01, d=1.6; Figure 2). 
 
*** Table 2 and Figure 2 near here *** 
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Perceptual variables 
 
There were no differences for PRE over time or between treatments. With the 
exception of CAF pre-exercise (8±2) and PLA pre-ingestion (6±2) PRE at all time 
points was 7±2-3 units. In contrast, there were significant main effects for time for 
RPEL (P<0.001, η2=0.9) and RPEO (P<0.001, η2=0.9). Largely, the patterns of change 
for both RPEL and RPEO were similar for all treatments over time although, 
interestingly, mean RPEL for BIC-CAF was ~1 unit lower across all time points 
compared with all other treatments (Table 3). Similarly, mean RPEO for BIC-CAF was 
~1 unit lower compared with all treatments after 1 min of TLIM and 1 unit lower than 
BIC and PLA after 2 min of TLIM (Table 3). 
 
*** Table 3 near here*** 
 
A significant time * treatment interaction was observed for abdominal discomfort (AD; 
P=0.012; η2=0.2). Abdominal discomfort was significantly greater for both BIC-CAF 
and BIC pre-exercise (3±2) and at the end of exercise (3±3) compared to PLA (1±2 
and 1±2, respectively; P<0.01). With the exception of PLA, AD was significantly 
greater pre-exercise when compared to pre-ingestion (1±1 for all treatments) for CAF 
(P<0.05) and both BIC and BIC-CAF (P<0.01). Similarly, AD was also significantly 
greater at the end of exercise for CAF, BIC and BIC-CAF (P<0.01) with a typical 
increase of ~2 units from pre-ingestion. There were no differences in AD over time for 
PLA. There were no differences for gut fullness (GF) over time or between treatments. 
The highest mean ratings of GF were for BIC-CAF (4±1) and BIC (4±1) 30 min post-
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ingestion. All other mean ratings of GF across all time points, regardless of treatment, 
ranged between 2 and 3 units.  
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Discussion 
 
To the best of our knowledge this is the first study to evaluate the effects of ingesting 
caffeine (CAF) or sodium bicarbonate (BIC) individually and in combination (BIC-CAF) 
on high-intensity cycling capacity at 100% WPEAK in healthy non-cycling trained males. 
In contrast to our original hypothesis at the group level ingesting CAF and BIC 
individually did not enhance TLIM compared with ingestion of a sodium chloride placebo 
(PLA). Such results are in contrast to the previously reported individual ergogenicity 
of CAF (Simmonds et al. 2010) and BIC (Higgins et al. 2013a). Similarly, ingestion of 
BIC-CAF at the group level did not enhance TLIM compared with PLA or CAF although 
TLIM was significantly greater for CAF and BIC-CAF compared to BIC. However, it 
should be acknowledged that there was reasonably significant inter and intra individual 
variation when comparing treatments (Table 1). For example, although both CAF and 
BIC-CAF had greater TLIM than BIC at the group level, this was not the case for 4/13 
(30%) of participants. Moreover, the range of individual responses for those who 
improved with CAF and BIC-CAF compared to BIC (29 to 170 s and 29 to 280 s, 
respectively) and those who didn’t (-95 to 6 s and -163 to 11s, respectively) was 
considerable. Similarly, although not significant at the group level TLIM was enhanced 
beyond daily variation in 8/13 (70%) participants for BIC-CAF vs. PLA. Finally, there 
was no fixed pattern when examining intra individual responses. For example, 
participant 9 reported greater TLIM for CAF vs BIC but not for CAF vs. PLA or BIC-CAF. 
Similarly, participant 1 reported greater TLIM for BIC-CAF vs. BIC but not vs. PLA. Such 
inter and intra individual variation might not necessarily be obvious when examining 
the individual responses in Table 1 as they are ordered low:high to allow reporting of 
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95%CI and median data. In summary, although there appear to be some relatively 
definitive trends, we suggest an individual approach to supplementation is warranted. 
 
Interestingly, differences between treatments in the present study are virtually 
opposite to those reported by Kilding et al. (2012) who evaluated 3km time trial (TT) 
cycling performance in trained males. The authors reported that, CAF (-1.0%), BIC (-
1.2%) and BIC-CAF (-1.2%) substantially improved TT performance compared to PLA. 
In contrast, differences between CAF and BIC (0.3%) CAF and BIC-CAF (0.2%) and 
BIC-CAF and BIC (0.0%) were insubstantial. However, both the present study and 
Kilding et al. (2012) appear to agree that differences between BIC-CAF and CAF are 
most likely trivial at best. The differences in results in the present study to those of 
Kilding et al. (2012) versus PLA are likely to be related to differences in training status 
(untrained vs. trained, respectively), caffeine dosage (5 mg.kg-1 vs. 3 mg.kg--1, 
respectively), exercise protocol (TLIM vs. 3 km TT, respectively) choice of PLA (taste 
matched NaCl vs. corn-flour, respectively),  method  of treatment ingestion (powder 
mixed with fluid based on body mass vs. capsules with fixed fluid amount, respectively) 
and timing of ingestion (single bolus with fluid and treatment related to body mass vs. 
serial ingestion with fixed fluid amounts). In summary, the results of the present study 
suggest that at the group level ingestion of 5.mg.kg-1 CAF enhances TLIM in healthy 
non-cycling trained males compared to 0.3 g.kg-1 BIC but a PLA might be equally as 
effective.  
 
As both BIC and PLA contain sodium (Na+) it is also plausible that changes in 
electrolyte balance could have influenced performance, at least in some individuals, 
as Na+ is a principal component of extracellular strong ion difference (Badr and 
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Nightingale 2007; Story et al. 2004). Indeed, Siegler and Gleadall-Siddall (2010) 
reported that ingesting 0.045 g.kg-1 PLA reduced Na+ levels by 1.7 mmol.l-1 compared 
to 0.3 g.kg-1 NaHCO3 when examining repeated swim performance in male and female 
University swimmers. In contrast, PLA resulted in 0.3 mmol.l-1 greater potassium (K+; 
also considered a strong cation) compared to NaHCO3 due to differences between 
treatments of 0.6 mmol.l-1 pre and post-exercise (i.e. no difference was observed pre-
ingestion). In contrast to the present study Siegler and Gleadall-Siddall (2010) 
reported an ergogenic benefit for NaHCO3 compared to PLA (-2% total swim time). 
The disparity in results to the present study could be related to differences in PLA 
dosage, participant cohort and exercise modality between studies. As electrolytes or 
strong ion difference were not measured in the present study further investigation as 
to if/how Na+/strong ion difference influences high-intensity cycling performance 
appears warranted. 
 
In the present study HR was greater for BIC-CAF and CAF compared to PLA at the 
end of exercise. Similarly, five minutes post-exercise HR was greater for BIC-CAF 
compared to all other treatments. Given the well known sympathetic nervous 
stimulating properties of CAF (and the moderate dose administered) it is unsurprising 
that HR was elevated for BIC-CAF and CAF vs. PLA pre-exercise. Moreover, Higgins 
et al. (2013a) reported that the same dosage of BIC in the present study elevated HR 
by 5 bpm-1 compared to PLA. As such, it also seems unsurprising that BIC-CAF 
reported the greatest HR 5-min post-exercise compared with other treatments. With 
no differences between treatments for V̇O2, V̇E and RER it appears that, at the group 
level, changes in cardiovascular physiology don’t explain the apparent diversity of TLIM 
between treatments. 
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It has previously been suggested that a difference of more than 2 mmol.l-1 peak [BLa] 
is needed to observe a significant improvement after BIC ingestion versus PLA (Ibanez 
et al. 1995). In the present study there were a number of instances at the end of 
exercise (BIC-CAF vs. PLA, BIC vs. PLA and BIC-CAF vs. CAF) and 5 min post-
exercise (BIC-CAF vs. PLA, BIC vs. PLA and BIC-CAF vs. CAF) where a differential 
of 2 mmol.l-1 [BLa] was observed. However, given that TLIM was greatest after CAF 
and that BIC-CAF and BIC did not increase TLIM versus PLA, it is suggested that 
augmented metabolic flux as indicated by differences in peak [BLa] is not necessarily 
an accurate marker for enhanced exercise performance when BIC is ingested 
individually or with CAF (Higgins et al. 2013a). 
  
After ingesting BIC and BIC-CAF pre-exercise pH was significantly elevated in 
comparison to both pre-ingestion values and pre-exercise values for PLA and CAF. 
The increases of 5 and 6 units compared to pre-ingestion for BIC-CAF and BIC, 
respectively, and 6 and 7 units compared to pre-exercise CAF and PLA, respectively, 
demonstrate pre-exercise alkalosis was successfully achieved. A similar pattern was 
observed for [HCO3-] with increases of 7 and 8 mmol.l-1 compared with pre-ingestion 
for BIC-CAF and BIC, respectively, and increases of between 7 and 8 mmol.l-1 
compared with pre-exercise CAF and PLA, respectively. However, despite augmented 
pre-exercise alkalosis BIC does not appear to have positively influenced TLIM. Indeed 
median TLIM for BIC was the lowest for all treatments in the present study (313 s) and 
substantially lower than a similar cohort measured previously in our laboratory (383 s; 
Higgins et al. 2013a). Interestingly, recovery of pH 5 min post-exercise was greater for 
BIC compared to all treatments. Further investigation to understand the differences in 
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TLIM between studies for BIC and if/how improved recovery of pH might affect 
subsequent exercise performance is warranted. 
  
In contrast, to previous research (Higgins et al. 2013a) there were no significant 
differences between treatments for RPEL or RPEO indicating at the group level 
differences in RPE don’t appear to explain differences in TLIM. However, mean RPEL  
for BIC-CAF was ~1 unit lower at all time points compared with all other treatments 
and mean RPEO for BIC-CAF was ~ 1 unit lower compared with all treatments after 1 
minute TLIM and ~1 unit lower than BIC and PLA after 2 minutes TLIM (Table 3). These 
differences might have contributed to the increased TLIM for BIC-CAF compared to BIC 
in some individuals (Table 1).  
 
Mean ratings of AD were significantly greater for both BIC-CAF and BIC pre-exercise 
(3±2) and at the end of exercise (3±3) compared to PLA (1±2 and 1±2, respectively). 
Prima facie, as these values are low/mild it could be suggested that at the group level 
AD has had minimal effects on TLIM. These data are consistent with previous work in 
our laboratory using the same dosage of NaHCO3 (Higgins et al. 2013a). Moreover, 
post-hoc correlational analysis revealed no group level relationship between AD and 
TLIM for any treatment. However, when analysing the data across all post-ingestion 
time points for BIC containing trials (i.e. 3 * 13 = 39 scores), 9 out of 39 (23%) and 5 
out of 39 (13%) ratings of AD were rated 6 (moderate discomfort) or greater (range 6 
to 8) for BIC and BIC-CAF, respectively. In contrast, there was only one rating of 6 or 
above for CAF and none for PLA. Furthermore, AD was lowest overall for PLA 
highlighting that the dosage of NaCl used was well tolerated when used in isolation 
(Higgins et al. 2013a). It seems plausible that AD might have negatively influenced 
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some individuals in some BIC or BIC-CAF trials which might help to explain, at least 
in part, the relatively large inter and intra variation in TLIM between treatments. 
Moreover, although NaHCO3-based solutions have been used in a variety of 
contemporary literature (Higgins et al. 2013a; Price and Simons 2010; Siegler and 
Gleadall-Siddall 2010), it is also possible that the use of solutions as opposed to 
capsules might have increased AD for some individuals. However, it should also be 
acknowledged that GI distress does not always negatively impact exercise 
performance (Higgins et al. 2013a; Price and Simons 2010).  
 
In conclusion when considering nutritional supplementation prior to high-intensity 
exercise at the group level, 5 mg.kg-1 caffeine, 0.3 g.kg-1 NaHCO3 or their co-ingestion 
do not appear to augment exercise capacity in healthy but not specifically cycling 
trained males when compared with a sodium chloride placebo. However, based on the 
inter and intra variation of results presented in this study and previously reported 
ergogenic effects of individually ingested caffeine and NaHCO3 we believe an 
individual approach to supplementation is warranted. 
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Table 1 – Individual and median differences in TLIM (s) between treatments.  
  CAF vs. BICa BIC-CAF vs. BICb PLA vs. BICc CAF vs. PLAd CAF vs. BIC-CAFe BIC-CAF vs. PLAf 
  -95 -163 -116 -139 -251 -84 
  -49 -15 -81 -66 -54 -47 
Lower 
95% CI -9 3 -32 -34 -38 -25 
  6 11 -15 12 -34 -3 
  29 29 -13 19 -28 0 
  29 44 17 20 -12 18 
Median 39 54 47 21 -11 35 
  84 61 54 22 -6 50 
  100 67 64 23 18 57 
Upper 
95% CI 102 106 88 56 23 71 
  107 118 89 60 48 110 
  145 199 95 116 68 112 
  170 280 168 183 141 135 
a CAF > BIC; P =0.039; r=0.6, b BIC-CAF > BIC; P=0.028; r=0.6, c P=0.196, r=0.4, d P=0.249, r=0.3, e P=0.753, r=0.1, f P=0.099, r=0.5 
 
NB: data in bold represents greater than daily variation of 16 s (Higgins et al. 2014) 
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Table 2 – Bicarbonate ion concentration [HCO3-] and base excess [BE] over time. # > 
CAF and PLA (P<0.01), * > CAF (P<0.01), $ > PLA (P<0.05), + > CAF (P<0.05). 
 
 
Treatment Pre-Ingestion Pre-Exercise 
End of 
Exercise 
5 Mins Post-
Exercise 
[H
C
O
3
- ]
 m
m
o
l.
l-1
  
CAF 25 ± 2 25 ± 2 13 ± 3 13 ± 3 
BIC 25 ± 2 33 ± 1 # 18 ± 4 # 18 ± 4 # 
BIC-CAF  24 ± 2 31 ± 2 # 16 ± 4 * $ 16 ± 4 * 
PLA 24 ± 3 24 ± 2 14 ± 3 13 ± 4 
[B
E
] 
m
m
o
l.
l-1
 CAF 1  ± 1 1  ± 1 -14 ± 3 -14 ± 4 
BIC  1  ± 1 9 ± 1 # -7 ± 4 # -6 ± 5 # 
BIC-CAF 0 ± 2 7 ± 2 # -9 ± 4 + -7 ± 9 # 
PLA 1  ± 2 0 ± 1 -13 ± 4 -13 ± 5 
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Table 3 – Ratings of perceived exertion localised to the leg musculature (RPEL) and 
overall cardiovascular strain (RPEO) over time (* all time points significantly different 
from each other; P<0.001). 
 
Treatment 1 min TLIM 2 min TLIM 3 min TLIM 
End of 
Exercise 
R
P
E
L
 
CAF 12  ± 2 14 ± 2 16 ± 2 20 ± 1 
BIC 12  ± 1 14 ± 1 16 ± 1 20 ± 1 
BIC-CAF 11  ± 2 13 ± 2 15 ± 2 19 ± 1 
PLA 12  ± 2 14 ± 2 16 ± 1 20 ± 1 
Mean * 12  ± 2 14 ± 2 16 ± 1 20 ± 1 
 
     
 
Treatment 1 min TLIM 2 min TLIM 3 min TLIM 
End of 
Exercise 
R
P
E
O
 
CAF 11 ± 2 12 ± 2 13 ± 2 19 ± 2 
BIC 11 ± 2 13 ± 2 14 ± 2 19 ± 2 
BIC-CAF 10 ± 2 12 ± 2 14 ± 3 19 ± 1 
PLA 11 ± 2 13 ± 2 14 ± 2 19 ± 2 
Mean * 11 ± 2 12 ± 2 14 ± 2 19 ± 1 
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Figure Captions 
 
Figure 1 – Time to volitional exhaustion (TLIM) at 100% WPEAK. Error bars represent the 
full range of scores for each treatment. The intersection between the open and closed 
boxes represents the median whereas the overall box represents the IQR. 
 
Figure 2 – pH over time. Error bars represent ± 1SD (some omitted for clarity). * BIC-
CAF and BIC > CAF and PLA (P<0.01). # BIC > CAF and PLA (P<0.01), BIC-CAF 
(P=0.01). 
